Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia-Reference-Cited by-同舟云学术

Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia

Published:2016-04-12 Issue:suppl_C Volume:18 Page:C2-C12
ISSN:1554-2815
Container-title:European Heart Journal Supplements
language:en
Short-container-title:

Author:

Ferrari Roberto,Aguiar Carlos,Alegria Eduardo,Bonadonna Riccardo C.,Cosentino Francesco,Elisaf Moses,Farnier Michel,Ferrières Jean,Filardi Pasquale Perrone,Hancu Nicolae,Kayikcioglu Meral,Mello e Silva Alberto,Millan Jesus,Reiner Željko,Tokgozoglu Lale,Valensi Paul,Viigimaa Margus,Vrablik Michal,Zambon Alberto,Zamorano José Luis,Catapano Alberico L.

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartjsupp/article-pdf/18/suppl_C/C2/9722519/suw009.pdf

Reference56 articles.

1. Ezetimibe added to statin therapy after acute coronary syndromes;N Engl J Med,2015

2. A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: a report from an expert consensus meeting on the role of fenofibrate–statin combination therapy;Atheroscler Suppl,2015

3. Residual macrovascular risk in 2013: what have we learned?;Cardiovasc Diabetol,2014

4. Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada;Eur J Prev Cardiol,2012

5. Persistent lipid abnormalities in statin-treated patients with diabetes mellitus in Europe and Canada: results of the Dyslipidaemia International Study;Diabet Med,2011

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of drugs in residual cardiovascular risk: A systematic review of the literature;International Journal of Cardiology Cardiovascular Risk and Prevention;2024-09

2. The role of residual inflammatory risk and LDL cholesterol in patients with in-stent restenosis undergoing percutaneous coronary intervention;Journal of Clinical Lipidology;2024-06

3. Role of Lipoprotein Ratios and Remnant Cholesterol in Patients with Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA);Journal of Cardiovascular Development and Disease;2024-05-08

4. Evaluation of measured and calculated small dense low-density lipoprotein in capillary blood and association with the metabolic syndrome;Clinica Chimica Acta;2024-04

5. Lipid Profile and Cardiovascular Risk Modification after Hepatitis C Virus Eradication;Pathogens;2024-03-25